| Conscious Healing Therapy Pllc | |
|
569 Wildwood Ave Unit 4 Jackson MI 49201-1048 | |
| (734) 219-9636 | |
| Not Available |
| Full Name | Conscious Healing Therapy Pllc |
|---|---|
| Speciality | Counselor |
| Location | 569 Wildwood Ave Unit 4, Jackson, Michigan |
| Authorized Official Name and Position | Mary Beth Houpt (CREDENTIALING) |
| Authorized Official Contact | 5176769797 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Conscious Healing Therapy Pllc Po Box 10 Mason MI 48854-0010 Ph: () - | Conscious Healing Therapy Pllc 569 Wildwood Ave Unit 4 Jackson MI 49201-1048 Ph: (734) 219-9636 |
| NPI Number | 1124626577 |
|---|---|
| Provider Enumeration Date | 10/16/2020 |
| Last Update Date | 12/20/2023 |
| Certification Date | 12/20/2023 |
| Medicare PECOS PAC ID | 4587014089 |
|---|---|
| Medicare Enrollment ID | O20231226000653 |
News Archive
A recent large German study has shown that a new combination therapy for breast cancer treatment leads to a lowered risk of the disease coming back. A commentary on this landmark clinical trial has been published in the latest issue of the Journal of Clinical Oncology by the researchers Masey Ross and Charles Geyer Jr. from the VCU Massey Cancer Center. The commentary was titled, "Nab-Paclitaxel: A New Standard of Care in Neoadjuvant Therapy of High-Risk Early Breast Cancer?"
Researchers from Medical University of South Carolina (MUSC) have discovered the use of thioredoxin – a naturally occurring antioxidant to modulate T cells of the immune system. This may be a big step towards improving currently used immune therapies such as adoptive T-cell therapy (ACT) and hematopoietic stem cell transplantation (HSCT).
Cangene Corporation today announces that it is developing an Immune Globulin Intravenous product, commonly known as IGIV. IGIV is a widely used anti-infective with a variety of indications including treating primary immune deficiency, immune thrombocytopenic purpura and other inflammatory and autoimmune diseases.
Newly discovered molecular differences between small cell lung cancer and nonsmall cell lung cancer have revealed PARP1 and EZH2 as potential therapeutic targets for patients with small cell lung cancer, according to the results of a study published in Cancer Discovery, a journal of the American Association for Cancer Research.
› Verified 9 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1124626577 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 101Y00000X | Counselor | (* (Not Available)) | Primary |
| Provider Name | Cassondra K Mcginn |
|---|---|
| Provider Type | Practitioner - Mental Health Counselor |
| Provider Identifiers | NPI Number: 1992008619 PECOS PAC ID: 5496105991 Enrollment ID: I20231226000677 |
News Archive
A recent large German study has shown that a new combination therapy for breast cancer treatment leads to a lowered risk of the disease coming back. A commentary on this landmark clinical trial has been published in the latest issue of the Journal of Clinical Oncology by the researchers Masey Ross and Charles Geyer Jr. from the VCU Massey Cancer Center. The commentary was titled, "Nab-Paclitaxel: A New Standard of Care in Neoadjuvant Therapy of High-Risk Early Breast Cancer?"
Researchers from Medical University of South Carolina (MUSC) have discovered the use of thioredoxin – a naturally occurring antioxidant to modulate T cells of the immune system. This may be a big step towards improving currently used immune therapies such as adoptive T-cell therapy (ACT) and hematopoietic stem cell transplantation (HSCT).
Cangene Corporation today announces that it is developing an Immune Globulin Intravenous product, commonly known as IGIV. IGIV is a widely used anti-infective with a variety of indications including treating primary immune deficiency, immune thrombocytopenic purpura and other inflammatory and autoimmune diseases.
Newly discovered molecular differences between small cell lung cancer and nonsmall cell lung cancer have revealed PARP1 and EZH2 as potential therapeutic targets for patients with small cell lung cancer, according to the results of a study published in Cancer Discovery, a journal of the American Association for Cancer Research.
› Verified 9 days ago
News Archive
A recent large German study has shown that a new combination therapy for breast cancer treatment leads to a lowered risk of the disease coming back. A commentary on this landmark clinical trial has been published in the latest issue of the Journal of Clinical Oncology by the researchers Masey Ross and Charles Geyer Jr. from the VCU Massey Cancer Center. The commentary was titled, "Nab-Paclitaxel: A New Standard of Care in Neoadjuvant Therapy of High-Risk Early Breast Cancer?"
Researchers from Medical University of South Carolina (MUSC) have discovered the use of thioredoxin – a naturally occurring antioxidant to modulate T cells of the immune system. This may be a big step towards improving currently used immune therapies such as adoptive T-cell therapy (ACT) and hematopoietic stem cell transplantation (HSCT).
Cangene Corporation today announces that it is developing an Immune Globulin Intravenous product, commonly known as IGIV. IGIV is a widely used anti-infective with a variety of indications including treating primary immune deficiency, immune thrombocytopenic purpura and other inflammatory and autoimmune diseases.
Newly discovered molecular differences between small cell lung cancer and nonsmall cell lung cancer have revealed PARP1 and EZH2 as potential therapeutic targets for patients with small cell lung cancer, according to the results of a study published in Cancer Discovery, a journal of the American Association for Cancer Research.
› Verified 9 days ago
Alexis Ahlbaum Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 5633 Poplar Dr, Jackson, MI 49201 Phone: 517-270-1994 | |
Cycle Of Life Support Chs Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 1520 E Ganson St, Jackson, MI 49202 Phone: 616-275-8930 Fax: 616-608-3693 | |
Inner Guidance Counseling Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 608 W Michigan Ave, Jackson, MI 49201 Phone: 517-416-8878 Fax: 517-962-5316 | |
Center For Family Health Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 505 N Jackson St, Jackson, MI 49201 Phone: 517-748-5500 | |
Lifeways Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 1200 N. West Avenue, Jackson, MI 49202 Phone: 517-780-3332 Fax: 517-796-4532 | |
Highfields Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 1206 Clinton Rd, Jackson, MI 49202 Phone: 517-783-4250 | |
Lifeways Mental Health Clinic Medicare: Medicare Enrolled Practice Location: 1200 N. West Avenue, Jackson, MI 49202 Phone: 517-789-1200 Fax: 517-789-1276 |